序号 |
标题 |
次数 |
作者 |
发布时间 |
61561 |
cas:322647-59-6 1-棕榈酰-2-亚油酰-sn-甘油-3-磷酸单钠盐(PLinPA-Na) |
70 |
zyl |
2025-01-02 |
61562 |
cas:40290-32-2 (消旋)-1,2-二棕榈酰-甘油醇 |
87 |
zyl |
2025-01-02 |
61563 |
cas:10567-21-2,(S)-1,2-二硬脂酰-sn-甘油醇,1,2-DISTEAROYL-SN-GLYCEROL |
98 |
axc |
2025-01-02 |
61564 |
cas:109786-74-5 (R)-3-(4-甲氧基苄氧基)-1,2-丙二醇 |
59 |
zyl |
2025-01-02 |
61565 |
cas:134979-01-4,2-(2-(2-氨基乙氧基)乙氧基)乙酸盐酸盐(AEEA盐酸盐),H-AEEA-OH.HCl,2-(2-(2-Aminoethoxy)ethoxy)acetic acid hydrochloride |
115 |
axc |
2025-01-02 |
61566 |
mPEG-EO,甲氧基PEG环氧乙烷 |
92 |
axc |
2025-01-02 |
61567 |
DSG-PEG 5000,cas:308805-39-2,1,2-二硬脂酰-rac-甘油-3-甲氧基聚乙二醇5000 |
84 |
axc |
2025-01-02 |
61568 |
DOctPA(Na),cas:321883-54-9,1,2- 双辛酰-sn-甘油-3-磷酸单钠盐 |
127 |
axc |
2025-01-02 |
61569 |
顺反DOTMA-Cl,cas:104872-42-6,(顺反)-1,2-二油烷氧基-3-(三甲铵基)丙烷氯盐 |
123 |
axc |
2025-01-02 |
61570 |
(S)-DPPE,cas:71357-99-8,(S)-二棕榈酰磷脂酰乙醇胺(手性异构体) |
79 |
axc |
2025-01-02 |
61571 |
SLinPS,cas:322647-11-0,1-硬脂酰-2-亚油酰磷脂酰丝氨酸(钠盐) |
73 |
axc |
2025-01-02 |
61572 |
cas:1353897-91-2,1-棕榈酰基-2-炔丙基乙酰磷脂酰胆碱,1-palmitoyl-2-(propargylacetyl)-sn-glycero-3-phosphocholine |
83 |
axc |
2025-01-02 |
61573 |
DPhPC,cas:207131-40-6,二植酰磷脂酰胆碱 |
77 |
axc |
2025-01-02 |
61574 |
DSPE-MPEG2000,cas:147867-65-0,二硬脂酰磷脂酰乙醇胺-聚乙二醇2000 |
128 |
axc |
2025-01-02 |
61575 |
DPPE,cas:923-61-5,磷脂酰乙醇胺,1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine |
138 |
axc |
2025-01-02 |
61576 |
P-LysoPC,cas:17364-16-8,1-十六酰-sn-丙三醇-磷酸胆碱 |
106 |
axc |
2025-01-02 |
61577 |
DLPC,cas:18194-25-7,1,2-二月桂酰基-sn-glycero-3-胆碱磷酸 |
70 |
axc |
2025-01-02 |
61578 |
HSPC/Chol/DSPE-mPEG2000/MPL (56.2/38.5/4.3/1, mol/mol) Liposomes,HSPC/Chol/DSPE-mPEG2000/MPL脂质体 |
85 |
axc |
2024-12-31 |
61579 |
DOTAP/DOPE (50/50, mol/mol) Liposomes,DOTAP/DOPE (50/50,摩尔/摩尔)脂质体 |
103 |
axc |
2024-12-31 |
61580 |
Adavosertib Liposomes, Formulation WD4,阿达沃塞替布脂质体,制剂WD4 |
245 |
axc |
2024-12-31 |
61581 |
Mirdametinib (PD0325901) Liposomes, Formulation U6-2,Mirdametinib (PD0325901)脂质体,配方U6-2 |
145 |
axc |
2024-12-31 |
61582 |
DT-061 (SMAP) Liposomes, Formulation TT-40,DT-061 (SMAP)脂质体,制剂TT-40 |
97 |
axc |
2024-12-31 |
61583 |
Tanespimycin (17-AAG) Liposomes, Formulation XT28.1,坦那霉素(17-AAG)脂质体,配方XT28.1 |
97 |
axc |
2024-12-31 |
61584 |
Nexturastat A Liposomes,Nexturastat A脂质体,靶向脂质体定制服务 |
93 |
axc |
2024-12-31 |
61585 |
A939572 Liposomes,A939572脂质体,靶向脂质体定制服务 |
119 |
axc |
2024-12-31 |
61586 |
Eganelisib (IPI-549) Liposomes, Formulation WNX5.2,Eganelisib (IPI-549)脂质体,制剂WNX5.2 |
156 |
axc |
2024-12-31 |
61587 |
Lificiguat (YC-1) Liposomes, Formulation FNT8P.2,Lificiguat (YC-1)脂质体,制剂FNT8P.2 |
79 |
axc |
2024-12-31 |
61588 |
SP600125 Liposomes, Formulation HZ12,SP600125脂质体,配方HZ12 |
97 |
axc |
2024-12-31 |
61589 |
Rocaglamide Liposomes, Formulation KHE9A,罗卡酰胺脂质体,配方KHE9A |
92 |
axc |
2024-12-31 |
61590 |
Gilteritinib (ASP2215) Liposomes,吉尔替尼(ASP2215)脂质体 |
86 |
axc |
2024-12-31 |
61591 |
CAS:125503-35-7 双(2,5-二氧吡咯烷-1-基)2,2'-(丙烷-2,2-二基双(磺胺基)二乙酸酯) |
108 |
zhn |
2024-12-31 |
61592 |
AZD1208 Liposomes, Formulation RB4T4,AZD1208脂质体,配方RB4T4 |
64 |
axc |
2024-12-31 |
61593 |
DiR Labeled Tumor-Accumulating Liposomes邃,DiR标记的肿瘤积聚脂质体 |
90 |
axc |
2024-12-31 |
61594 |
氧化锌量子点(ZnO QDs) 无机半导体材料 |
175 |
zhn |
2024-12-31 |
61595 |
聚多巴胺微球 |
165 |
zhn |
2024-12-31 |
61596 |
PS-R-PMMA 聚苯乙烯(PS)和聚甲基丙烯酸甲酯(PMMA)共聚物 |
282 |
zhn |
2024-12-31 |
61597 |
AgBiS₂量子点 银铋硫化物量子点 |
112 |
zhn |
2024-12-31 |
61598 |
单层石墨相氮化碳纳米片(Graphitic Carbon Nitride, g-C₃N₄) |
217 |
zhn |
2024-12-31 |
61599 |
HSPC/胆固醇/DSPE-mPEG2000 (56.2/38.5/5.3,摩尔/摩尔)脂质体(DiD标记),脂质体定制服务 |
117 |
axc |
2024-12-31 |
61600 |
HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) Liposomes (DiD-labeled),脂质体定制服务 |
119 |
axc |
2024-12-31 |
61601 |
环糊精修饰螺吡类分子 |
79 |
zhn |
2024-12-31 |
61602 |
HSPC/胆固醇/DSPE-聚乙二醇2000/DSPE-聚乙二醇2000-马来酰亚胺(50/45/4/1,摩尔/摩尔)脂质体,脂质体定制服务 |
117 |
axc |
2024-12-31 |
61603 |
二氧化硅包纳米金棒 SiO₂@Au nanorods |
95 |
zhn |
2024-12-31 |
61604 |
HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide (50/45/4/1, mol/mol) Liposomes,脂质体定制服务 |
122 |
axc |
2024-12-31 |
61605 |
四氧化三铁二硫化钼复合材料 Fe₃O₄@MoS₂ |
218 |
zhn |
2024-12-31 |